Gómez J M, Maravall F J, Gumà A, Abós R, Soler J, Fernández-Castañer M
Endocrine Unit, Ciudad Sanitaria y Universitaria de Bellvitge, Barcelona, Spain.
Horm Metab Res. 2003 Aug;35(8):486-91. doi: 10.1055/s-2003-41806.
The aim of this cross-sectional study was to assess and compare thyroid volume and its derminants in a cohort of type 1 diabetes mellitus (DM1) and compare the results to a healthy control group. We studied 65 DM1 patients treated with an intensive insulin regimen and 65 matched controls. In all participants we evaluated weight, height, BMI, waist-hip ratio, body surface area and body composition variables determined by using a bioelectrical impedance analyser. Thyroid size was estimated by ultrasonography. We determined basal TSH, anti-thyroid antibodies and urinary iodine excretion. Body weight, height, BMI and body surface area were similar in DM1 patients and in controls. Fat-free mass was higher in both male and female DM1 patients than in controls (64.4 +/- 6.9 vs. 60.4 +/- 8.2 kg, p=0.03 and 48.3 +/- 5.7 vs. 45.4 +/- 6, p=0.04, respectively), and fat mass was lower in male DM1 patients than in controls (9.7 +/- 7 vs. 14.2 +/- 8.1 kg, p=0.01). Thyroid volume was greater in both male and female DM1 patients than in controls (11.12 +/- 2.87 vs. 9.63 +/- 2.27 ml, p=0.0001 and 9.5 +/- 2.3 vs. 7.7 +/- 2 ml, p=0.002, respectively). Urinary iodine excretion was similar in the two groups. In both DM1 patients and controls, thyroid volume correlated with weight, height, BMI, waist-hip ratio, body surface area, fat-free mass and the multivariate linear regression analysis with thyroid volume as the dependent variable showed that fat-free mass in either group was the only significant determinant of thyroid volume. We conclude that DM1 patients had larger thyroid volume compared with healthy controls with similar anthropometry; body composition is different in DM1 patients and that the anthropometric and body composition variables, especially fat-free mass and body surface area, predict thyroid volume either in DM1 patients or in healthy controls.
这项横断面研究的目的是评估和比较1型糖尿病(DM1)队列中的甲状腺体积及其决定因素,并将结果与健康对照组进行比较。我们研究了65例接受强化胰岛素治疗方案的DM1患者和65例匹配的对照组。在所有参与者中,我们评估了体重、身高、体重指数(BMI)、腰臀比、体表面积以及使用生物电阻抗分析仪测定的身体成分变量。通过超声检查估计甲状腺大小。我们测定了基础促甲状腺激素(TSH)、抗甲状腺抗体和尿碘排泄量。DM1患者和对照组的体重、身高、BMI和体表面积相似。男性和女性DM1患者的去脂体重均高于对照组(分别为64.4±6.9 vs. 60.4±8.2 kg,p = 0.03;48.3±5.7 vs. 45.4±6,p = 0.04),男性DM1患者的脂肪量低于对照组(9.7±7 vs. 14.2±8.1 kg,p = 0.01)。男性和女性DM1患者的甲状腺体积均大于对照组(分别为11.12±2.87 vs. 9.63±2.27 ml,p = 0.0001;9.5±2.3 vs. 7.7±2 ml,p = 0.002)。两组的尿碘排泄量相似。在DM1患者和对照组中,甲状腺体积均与体重、身高、BMI、腰臀比、体表面积、去脂体重相关,以甲状腺体积作为因变量的多元线性回归分析表明,两组中的去脂体重是甲状腺体积的唯一显著决定因素。我们得出结论,与具有相似人体测量学特征的健康对照组相比,DM1患者的甲状腺体积更大;DM1患者的身体成分不同,人体测量学和身体成分变量,尤其是去脂体重和体表面积,可预测DM1患者或健康对照组的甲状腺体积。